Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Venkatesan Jay, Directeur. Director active across 5 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 11 reports have been published. Breakdown: 5 buys · 1 sell. Total volume traded: €3.5m. Activity tracked since 17 September 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Venkatesan Jay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
400,000 shares@ US$9.40100.0% of flowCommon StockSEC:0001626199-21-000113:0
11 of 11 declarations
About Venkatesan Jay
Venkatesan Jay is Director and has 11 filings in total. In the sampled recent filings, they cover the period from 2021-09-21 to 2026-04-21, with buys of EUR 292770 and sells of EUR 3195248, and the modal transaction nature is Acquisition. They are listed at Angion Biomedica Corp., Serina Therapeutics, Inc., Elicio Therapeutics, Inc., Alpine Immune Sciences, INC. and ALPINE IMMUNE SCIENCES, INC.